Bibliographic Details
| Title: |
ANTIINFECCIOSOS DE USO SISTÉMICO FALSIFICADOS Y SUBESTÁNDARES EN PERÚ. |
| Alternate Title: |
SUBSTANDARD AND FALSIFIED SYSTEMIC ANTI-INFECTIVES IN PERU. |
| Authors: |
Huamaní-Pacsi, Carlos1 chuamani.ins@gmail.com, Torres Olivera, Roberto2 |
| Source: |
Revista Peruana de Medicina Experimental y Salud Pública. 2026, Vol. 43 Issue 2, p224-230. 7p. |
| Abstract (English): |
Substandard and falsified (SF) systemic anti-infective (SAI) medications detected by the National Health Authority of Peru between 2015 and 2023 were quantified and characterized. An observational, descriptive, and retrospective design was applied, based on test reports issued by the National Quality Control Center on the quality of SAIs, complemented with national evidence of antimicrobial resistance (AMR). Of 9799 pharmaceutical products evaluated, 1247 (12.7%) were SF; of these, 189 (15.2%) corresponded to SF SAIs, with falsified ones predominating (11.0%). The main groups were β-lactams (27.5%), sulfonamides/trimethoprim (26.5%), and quinolones (12.7%). 59.8% had informal origin, mostly from Lima (72%). The circulation of SF SAI medications could promote selective pressure, the spread of AMR, and therapeutic failure. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
Se cuantificó y caracterizó medicamentos antiinfecciosos de uso sistémico (AUS) subestándares y falsificados (SF) pesquisados por la Autoridad Sanitaria Nacional del Perú entre 2015 y 2023. Se aplicó un diseño observacional, descriptivo y retrospectivo basado en informes de ensayo emitidos por el Centro Nacional de Control de Calidad sobre calidad de los AUS, complementados con evidencia nacional de resistencia antimicrobiana (RAM). De 9799 productos farmacéuticos evaluados, 1247 (12,7%) fueron SF; de estos, 189 (15,2%) correspondieron a AUS SF, predominando los falsificados (11,0%). Los principales grupos fueron β-lactámicos (27,5%), sulfonamidas/trimetoprima (26,5%) y quinolonas (12,7%). El 59,8% tuvieron procedencia informal, mayormente de Lima (72%). La circulación de medicamentos AUS SF podría favorecer la presión selectiva, propagación de la RAM y el fracaso terapéutico. [ABSTRACT FROM AUTHOR] |
|
Copyright of Revista Peruana de Medicina Experimental y Salud Pública is the property of Instituto Nacional de Salud (Peru) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
